Startup

Biocartis

Description

Biocartis is a molecular diagnostics company focused on enabling universal access to personalized medicine through its innovative Idylla Platform. This fully automated system offers real-time PCR-based molecular testing, providing fast and accurate results for informed treatment decisions. With a strong emphasis on oncology, Biocartis offers a range of tests supporting melanoma, colorectal, lung, breast, and liver cancer, as well as sepsis. The company's mission is to make molecular testing convenient, fast, and suitable for any lab, ultimately driving better health outcomes and reducing healthcare costs globally.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.